blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3530268

EP3530268 - THERAPEUTIC TREATMENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.10.2022
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  12.11.2021
FormerGrant of patent is intended
Status updated on  15.04.2021
FormerRequest for examination was made
Status updated on  28.02.2020
FormerThe application has been published
Status updated on  26.07.2019
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Attentive Therapeutics, Inc.
16055 Ventura Blvd., Ste. 670
Encino CA 91436 / US
[2021/49]
Former [2019/35]For all designated states
Sears, Douglas
4867 Wiggin Street
Oak Park, CA 91377 / US
For all designated states
Reilly, Michael
1225 Dumaine Avenue
Oak Park, CA 91377 / US
Inventor(s)01 / SEARS, Douglas
4867 Wiggin Street
Oak Park California 91377 / US
02 / REILLY, Michael
1225 Dumaine Avenue
Oak Park California 91377 / US
 [2021/49]
Former [2019/35]01 / see applicant
...
Representative(s)Grund, Martin
Grund Intellectual Property Group
Patentanwälte und Solicitor PartG mbB
Steinsdorfstraße 2
80538 München / DE
[N/P]
Former [2019/35]Grund, Martin
Grund Intellectual Property Group
Patentanwalt und Solicitor PartG mbB
Postfach 44 05 16
80754 München / DE
Application number, filing date19153534.304.10.2013
[2019/35]
Priority number, dateUS201261744948P09.10.2012         Original published format: US 201261744948 P
[2019/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3530268
Date:28.08.2019
Language:EN
[2019/35]
Type: B1 Patent specification 
No.:EP3530268
Date:15.12.2021
Language:EN
[2021/50]
Search report(s)(Supplementary) European search report - dispatched on:EP09.07.2019
ClassificationIPC:A61K31/135, A61K31/445, A61P25/00
[2019/35]
CPC:
A61K45/06 (EP,US); A61K31/137 (EP,US); A61K31/165 (EP,US);
A61K31/4458 (EP,US); A61K31/451 (EP,US); A61P25/00 (EP)
C-Set:
A61K31/137, A61K2300/00 (EP,US);
A61K31/165, A61K2300/00 (US,EP);
A61K31/4458, A61K2300/00 (US,EP);
A61K31/451, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/14]
Former [2019/35]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:THERAPEUTISCHE BEHANDLUNG[2019/35]
English:THERAPEUTIC TREATMENT[2019/35]
French:TRAITEMENT THÉRAPEUTIQUE[2019/35]
Examination procedure26.02.2020Examination requested  [2020/14]
26.02.2020Date on which the examining division has become responsible
07.04.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
04.06.2020Amendment by applicant (claims and/or description)
16.04.2021Communication of intention to grant the patent
16.08.2021Fee for grant paid
16.08.2021Fee for publishing/printing paid
16.08.2021Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP13846073.8  / EP2906208
Opposition(s)16.09.2022No opposition filed within time limit [2022/47]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
04.06.2020Request for further processing filed
04.06.2020Full payment received (date of receipt of payment)
Request granted
17.06.2020Decision despatched
Fees paidRenewal fee
10.05.2019Renewal fee patent year 03
10.05.2019Renewal fee patent year 04
10.05.2019Renewal fee patent year 05
10.05.2019Renewal fee patent year 06
23.10.2019Renewal fee patent year 07
14.10.2020Renewal fee patent year 08
27.10.2021Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU04.10.2013
AL15.12.2021
AT15.12.2021
CY15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
MK15.12.2021
MT15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
[2024/42]
Former [2024/27]HU04.10.2013
AL15.12.2021
AT15.12.2021
CY15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
MK15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2024/21]HU04.10.2013
AL15.12.2021
AT15.12.2021
CY15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2024/18]HU04.10.2013
AL15.12.2021
AT15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2023/25]AL15.12.2021
AT15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
MC15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2023/01]AL15.12.2021
AT15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SI15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/49]AL15.12.2021
AT15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/46]AT15.12.2021
CZ15.12.2021
DK15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/42]AT15.12.2021
CZ15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
IS15.04.2022
PT18.04.2022
Former [2022/36]AT15.12.2021
CZ15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
PL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
PT18.04.2022
Former [2022/35]CZ15.12.2021
EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SK15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
PT18.04.2022
Former [2022/34]EE15.12.2021
ES15.12.2021
FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
RO15.12.2021
RS15.12.2021
SE15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
PT18.04.2022
Former [2022/33]FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
RS15.12.2021
SE15.12.2021
SM15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
Former [2022/30]FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
NL15.12.2021
RS15.12.2021
SE15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
Former [2022/25]FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
RS15.12.2021
SE15.12.2021
BG15.03.2022
NO15.03.2022
GR16.03.2022
Former [2022/24]FI15.12.2021
HR15.12.2021
LT15.12.2021
LV15.12.2021
RS15.12.2021
SE15.12.2021
BG15.03.2022
GR16.03.2022
Former [2022/22]FI15.12.2021
LT15.12.2021
RS15.12.2021
BG15.03.2022
Former [2022/21]RS15.12.2021
BG15.03.2022
Former [2022/19]BG15.03.2022
Documents cited:Search[XY]  - L DODSON ET AL, "Reduce appetite suppression, insomnia in ADHD treatment", CURRENT PSYCHIATRY, (20050101), vol. 4, no. 7, pages 61 - 62, XP055249315 [X] 1-5,8,11,12,15 * the whole document * [Y] 1-15
 [XY]  - DAVISS W BURLESON ET AL, "A chart review of cyproheptadine for stimulant-induced weight loss.", JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, (200404), vol. 14, no. 1, ISSN 1044-5463, pages 65 - 73+2pp, XP002756111 [X] 1-12,15 * page 65, abstract * * page 71, column l, paragraph 2 * [Y] 1-15

DOI:   http://dx.doi.org/10.1089/104454604773840508
 [XY]  - PRINCE JEFFERSON B, "Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.", CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, (200601), vol. 15, no. 1, ISSN 1056-4993, pages 13 - 50, XP009189335 [X] 1-12,15 * page 31, paragraph 3 * [Y] 1-15
 [Y]  - DURA-TRAVE TEODORO ET AL, "Effects of Osmotic-Release Methylphenidate on Height and Weight in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Following up to Four Years of Treatment", JOURNAL OF CHILD NEUROLOGY, (201205), vol. 27, no. 5, pages 604 - 609, XP002756112 [Y] 1-15 * page 607, column l, paragraph 2 * * page 607, column r *
by applicantUS4756911
 US5378475
 US7048946
 US2005181017
 US2005244464
 US2011008437
    - GOODMAN DW, Primary Psychiatry, (20100000), vol. 17, page 2
    - "Physician's Desk Reference", Medical Economics, (19980000), vol. 52
    - KIBBE, A. H., Handbook of Pharmaceutical Excipients, American Pharmaceutical Association, (20000000), vol. 3
    - F. PODCZECK; B. JONES, Pharmaceutical Capules, (20040000), vol. 2
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.